News

Several NJ cannabis leaders and local celebrities were honored by Minorities for Medical Marijuana (M4MM) on their top 100 influencers list during Black History Month. According to High Times Magazine, the names were not ordered to say who is more influential than someone else on the list. We used their order. Entrepreneur, Advocate, and NBA [ . . . ] Source: Several NJ Cannabis Leaders Honored by Black History Month List from Heady NJ

While U.S. operators navigate federal uncertainty at home, Europe’s cannabis sector is expanding within the constraints of European Union agreements. Medical markets across the continent are gaining traction, Germany’s import volumes are climbing sharply, and adult-use reform is unfolding through cultivation associations and regional pilot programs rather than full commercial sales. In this interview, Alex Rogers of the International Cannabis Business Conference discusses the structural differences between the U.S. and European legalization models, the markets drawing the most attention in . . .

A Florida bill to significantly reduce the fee for military veterans to obtain medical marijuana registry identification cards has cleared another legislative committee. The House Health & Human Services Committee approved the measure from Reps. Susan Valdés (R) and Michelle Salzman (R) in a 22-0 vote on Tuesday. This comes after the legislation cleared two other House panels and as separate Senate legislation to reduce medical cannabis costs for veterans is also advancing. If HB 887 is enacted into law, veterans who have been honorably discharged would need to pay a $15 fee to obtain a . . .

Talk a walk through the hall of fame with our look back at past Leafly Strain of the Year winners. This year’s winner is announced March 4th. The post A look back at the Leafly Strain of the Year hall of fame appeared first on Leafly.

Virginia lawmakers have advanced a bill to legalize marijuana sales along another step in the bicameral legislative process, with a House committee approving a substitute version of a Senate-passed reform measure. The House General Laws Committee on Tuesday took up the legislation from Sen. Lashrecse Aird (D) and replaced its contents with the text of a House-passed version that’s being sponsored by the panel chair, Del. Paul Krizek (D), with some additional changes. The bill as revised passed 16-4, sending it to the Appropriations Committee for further consideration and setting the stage for . . .

The sponsor of the bill to eliminate the cannabis panel said it has become an unnecessary layer of bureaucracy. By Joshua Haiar, South Dakota Searchlight The controversial committee that oversees South Dakota’s medical marijuana program could come to an end. A bill sponsored by Rep. Tim Goodwin, R-Rapid City, that passed the House 41-26 on Monday would repeal the sections of state law that established the Medical Marijuana Oversight Committee. The bill goes to a Senate panel next. The medical marijuana program itself would continue, under the regulation of the state Department of Health. . . .

The Oregon House of Representatives has approved a bill that would allow patients with debilitating medical conditions to access medical marijuana in certain health facilities such as hospices. The legislation from Rep. Farrah Chaichi (D) cleared the chamber in a 39-3 vote on Friday, sending it to the Senate for consideration. That chamber’s Health Care Committee is scheduled to take up the proposal on Wednesday. HB 4142 would require hospice, palliative and home care organizations, as well as residential facilities, to develop rules permitting registered patients with debilitating conditions . . .

A GOP congressman is seeking to amend a large-scale agriculture bill to delay the federal recriminalization of hemp THC products for one year as industry stakeholders work to identify a long-term solution to the pending recriminalization-and a key House committee is expected to consider the proposal next week. The hemp sector has been sounding the alarm about the cannabinoid ban that was included in broader spending legislation President Donald Trump signed into law last year. They argue that the redefinition of what constitutes federally legal hemp-which is currently set to take effect in . . .

“Voters made their mandate clear in 2024, and now Nebraskans have been left vulnerable because their leaders refuse to respect it.” The post Nebraska Omitted from List of Medical Marijuana States Provided Federal Protections appeared first on NORML.

The market for hemp-derived products has grown significantly, leading to a wide range of quality tiers available for consumers to choose from today. Shoppers often find themselves comparing different options without knowing exactly what makes one product superior to another in the long run. Understanding these distinctions is the key to finding a satisfying and [ . . . ] Source: What Sets Premium THCA Flower Apart from Heady NJ

Support for legalizing the use of psychedelics might relatively low today, according to a new survey from the RAND Corporation, but public opinion on the issue seems be closely following in the footsteps of the marijuana reform movement before the first states started enacting cannabis legalization. As more states and localities, as well as Congress, see momentum around psychedelics reform, the poll that was released on Tuesday shows that Americans are currently feeling relatively tepid about the prospect of expanding access to hallucinogenic substances. However, there’s reason to believe . . .

In the last year or two, we have seen a growing number of marijuana businesses take the position that IRC 280E no longer applies to them. Some of these businesses have taken that position in consultation with lawyers and CPAs. This shift in strategy predates Trump’s Executive Order of December 18, 2025, to reschedule marijuana under the federal Controlled Substances Act (CSA). In any case, I believe this is a misreading of the law and a dangerous position for these businesses to take. What is IRC 280E? IRC 280E is a federal tax provision that prohibits businesses engaged in the “trafficking” . . .

“America does not have a marijuana crisis. It has a knowledge deficit, a training deficit and a regulatory deficit layered on top of decades of stigma.” By Jill Simonian and Codi Peterson, Pharmacists’ Cannabis Coalition of California The New York Times editorial board recently warned that America now faces a “marijuana problem,” suggesting that legalization has produced a public health crisis. That framing is misleading, and in contrast to that very same board’s previous recommendation. The piece’s headline collapses a complicated medical and regulatory landscape into an all-too-familiar . . .

As Virginia lawmakers push ahead with an effort to legalize marijuana sales in the commonwealth, certain GOP members are finding themselves ideologically aligned with their Democratic colleagues, breaking with the majority of their caucus in support of creating a regulated marketplace for adults to purchase cannabis. In a series of recent interviews, Republican legislators explained their votes last week to pass a House bill that would allow commercial cannabis sales at licensed retailers. The Senate similarly approved marijuana sales legislation last week, though it differs from the House . . .

Pennsylvania Gov. Josh Shapiro (D) again included adult-use cannabis legalization in his annual budget proposal, Philly Voice reports. Shapiro’s budget estimates that cannabis derived taxes and fees would bring $729.4 million to state coffers in the first year of implementation. The governor’s budget urges lawmakers to pass adult-use cannabis reforms, saying the state “remains stuck in place, without commonsense protections and losing out on critical tax revenue and new business to neighboring states.” Chris Goldstein, regional director for the National Organization for the Reform of . . .

A report from the Missouri state auditor released last week found that combined medical and adult-use sales in the state generated more than $255 million in tax revenues last year, but that there were significant flaws with the business application process, issues with dispensaries keeping customer data, and potential over-selling by dispensaries. The report from State Auditor Scott Fitzpatrick suggests that the problems with the licensing process – summarized as not ensuring consistency or transparency – cost the state more than $12.5 million in costs associated with litigation and . . .

Virginia medical cannabis sales totaled about $15.08 million in January, according to state Cannabis Control Board data included in a newly launched dashboard. The data shows medical cannabis sales in the state has remained steady over the last six months, reaching $15.18 million in August 2025, $13.83 million in September, $15.15 million in October, $14.41 million in November, and $15.62 million in December. Flower remained the most popular product category in the state in January, comprising $6.55 million in sales, while concentrates comprised $5.03 million, edible sales totaled $2.55 . . .

An equity group has asked Los Angeles Mayor Karen Bass (D) to reject a proposal to tax the city’s unlicensed operators. In a letter circulating today, non-profit Social Equity LA argues doing so would defeat the purpose of having a social equity program. This month City Council voted for Angelenos to vote on taxing unlicensed operators on June 2, the day of the California primary. Moving forward requires approval from Bass. Social Equity LA argues taxing unlicensed operators would lead to uneven enforcement and normalize illegal activity . . . Log in or become a WeedWeek Member to read this . . .

Every year, as the light softens over the hills of Humboldt and Mendocino, the cannabis world turns its attention to one of the most influential genetic selection events in the United States: the Humboldt Seed Company (HSC) Pheno Hunt. What began as a small internal project has evolved into a multi-farm, region-spanning collaboration that now shapes trends in hash, terpenes and genetic direction far beyond Northern California. With experts and connoisseurs from around the globe in attendance, it was truly one for the books. Spread across several notable farms in addition to HSC’s anchor farm . . .

Connecticut lawmakers are among the latest in the U.S. to take up legislation to allow medical marijuana use by certain qualifying patients at health facilities such as hospitals, nursing homes and hospices. Members of the legislature’s Joint Committee on Public Health convened to discuss the cannabis bill at a hearing on Monday, taking testimony from state agencies, medical institutions and more as they consider implementing a policy known as “Ryan’s law,” named after a young California medical cannabis patient who passed away. Under the proposal, terminally ill patients could access . . .

Hawaii senators have advanced a bill to create a psychedelics task force responsible for studying and making policy recommendations on providing access to breakthrough therapies such as psilocybin and MDMA. Members of the Senate Health and Human Services Committee approved the legislation from Sen. Chris Lee (D), with amendments, in a 5-0 vote on Wednesday. The measure would create a Mental Health Emerging Therapies Task Force that’d be tasked with spending two years reviewing the current scientific literature, supporting additional clinical research and “developing policy recommendations for . . .

A Florida campaign seeking to put marijuana legalization on the ballot is facing another complication as it continues to litigate the status of its 2026 signature drive. Under a new election law, the hundreds of thousands of signatures activists already collected for this year will not be carried over into the 2028 cycle. Gov. Ron DeSantis (R) signed a bill into law last year that makes several fundamental changes to the ballot process in a way that advocates say significantly undermines their ability to put citizen initiatives before voters, including a policy to reset the signature clock . . .

Mehmet Oz, the head of the Centers for Medicare & Medicaid Services (CMS), says “there are going to be consequences” as more Americans choose marijuana over alcohol-including problems caused by “high-dose hemp and CBD.” As the Trump administration works to finalize a cannabis rescheduling proposal and prepares to roll out a CBD coverage plan through Medicare under Oz’s agency, the health official curiously raised concerns about non-intoxicating cannabidiol and hemp products overall. During an interview with Katie Miller-the wife of top Trump advisor Stephen Miller-Oz was asked whether shifts . . .

Two months after President Trump issued an executive order directing his administration to move cannabis from Schedule I to Schedule III, it remains unclear whether the process is underway or when it could be finalized. Meanwhile, the Food and Drug Administration missed a deadline set by Congress to publish a list of known cannabinoids. So, where does cannabis rescheduling stand? RELATED: New hemp bill in Congress could bring big changes At the IgniteIt Market Spotlight in New Jersey this month, cannabis industry executives offered sharply different views on the timeline. Moderator Jeff . . .

An Arizona Senate committee last week advanced a proposal seeking to create a new misdemeanor crime for excessive cannabis smoke and odor, 13 News reports. The bill, SB1725, would treat the issue as a public nuisance concern, making it a class 3 misdemeanor to cause or create “excessive” cannabis smoke – even on private residential property. Another bill, SCR1048, seeks to put an identical proposal before voters as a ballot initiative. Neither bill explicitly defines what “excessive” means in the context of what qualifies as a public nuisance. The bill does, however, state that “it is . . .